The Information Transfer and Research Training core of the ADRC will continue to provide current knowledge about progress in Alzheimer's disease research, and will increase awareness and understanding of Alzheimer's disease to health professionals, the media and public, patient's families, community and Alzheimer's organizations, physicians-in-training, and practicing physicians. These groups will be able to utilize and incorporate these developments into their practices, improve the care of Alzheimer's patients, and further scientific investigation. These objectives will be accomplished through conferences, seminars, and presentations by ADRC and Department of Geriatrics, Psychiatry, other Mount Sinai staff, as well as staff from outside Alzheimer organizations and affiliates of mount Sinai, and through continued publication of the ADRC Newsletter. Continuing medical education programs for practicing physicians and health care professionals will continue to be held under a variety of co-sponsorships. The core will expand its outreach and educational efforts within minority communities. Outreach seminars and workshops in areas of Harlem and Queens will have a dual purpose: education and training of health care providers in the detection of memory disorders, and recruitment of subjects for clinical studies at Mount Sinai and its satellite centers. Off-site pilot programs will serve as models for the development of similar programs within the next five years. Educational programs that emphasize the care of Alzheimer's patients and also provide research opportunities, will be provided for medical students, residents, and fellows through fellowship programs in the Departments of Psychiatry and Geriatrics. Liaison with community and government agencies and organizations, and between Mount Sinai departments of Geriatrics, Neurobiology, Psychiatry, Social Work, and Molecular Biology, continues to facilitate information transfer and networking.

National Institute of Health (NIH)
National Institute on Aging (NIA)
Specialized Center (P50)
Project #
Application #
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Mount Sinai School of Medicine
New York
United States
Zip Code
Warren, Noel A; Voloudakis, Georgios; Yoon, Yonejung et al. (2018) The product of the ?-secretase processing of ephrinB2 regulates VE-cadherin complexes and angiogenesis. Cell Mol Life Sci 75:2813-2826
Ramsey, Christine M; Gnjidic, Danijela; Agogo, George O et al. (2018) Longitudinal patterns of potentially inappropriate medication use following incident dementia diagnosis. Alzheimers Dement (N Y) 4:1-10
Tsartsalis, Stergios; Xekardaki, Aikaterini; Hof, Patrick R et al. (2018) Early Alzheimer-type lesions in cognitively normal subjects. Neurobiol Aging 62:34-44
Ridge, Perry G; Karch, Celeste M; Hsu, Simon et al. (2018) Correction to: Linkage, whole genome sequence, and biological data implicate variants in RAB10 in Alzheimer's disease resilience. Genome Med 10:4
Pimenova, Anna A; Raj, Towfique; Goate, Alison M (2018) Untangling Genetic Risk for Alzheimer's Disease. Biol Psychiatry 83:300-310
Kirson, Noam Y; Scott Andrews, J; Desai, Urvi et al. (2018) Patient Characteristics and Outcomes Associated with Receiving an Earlier Versus Later Diagnosis of Probable Alzheimer's Disease. J Alzheimers Dis 61:295-307
Culverhouse, R C; Saccone, N L; Horton, A C et al. (2018) Collaborative meta-analysis finds no evidence of a strong interaction between stress and 5-HTTLPR genotype contributing to the development of depression. Mol Psychiatry 23:133-142
Edler, Melissa K; Sherwood, Chet C; Meindl, Richard S et al. (2018) Microglia changes associated to Alzheimer's disease pathology in aged chimpanzees. J Comp Neurol 526:2921-2936
Mitchell, A C; Javidfar, B; Pothula, V et al. (2018) MEF2C transcription factor is associated with the genetic and epigenetic risk architecture of schizophrenia and improves cognition in mice. Mol Psychiatry 23:123-132
Weintraub, Sandra; Besser, Lilah; Dodge, Hiroko H et al. (2018) Version 3 of the Alzheimer Disease Centers' Neuropsychological Test Battery in the Uniform Data Set (UDS). Alzheimer Dis Assoc Disord 32:10-17

Showing the most recent 10 out of 555 publications